A critical role for Slc5a8 in the suppression of colonic inflammation by commensal bacteria-derived metabolites (MUC9P.821)
作者
Ashish Gurav,Nagendra Singh,Vadivel Ganapathy
出处
期刊:Journal of Immunology [American Association of Immunologists] 日期:2014-05-01卷期号:192 (Supplement_1): 199.8-199.8被引量:2
标识
DOI:10.4049/jimmunol.192.supp.199.8
摘要
Abstract Presence of trillions of bacteria in healthy colon presents an immunological challenge. Colonic bacteria ferment dietary fibers into short-chain fatty acids (butyrate, propionate, and acetate; SCFAs); among which, butyrate and propionate are inhibitors of histone deacetylases (HDACs). Depletion of SCFAs correlates with increased incidence of intestinal inflammation. Slc5a8 is a high-affinity transporter for SCFAs, which is essential for intracellular actions of SCFAs such as HDAC inhibition. Among various immune cells in colon, dendritic cells (DCs) are unique in having access to colonic lumen, thus getting exposed to bacterial antigens. It is known that colonic DCs exhibit tolerogenic properties with ability to suppress conversion and proliferation of naïve T cells into pro-inflammatory T cells. However, the mechanisms involved in the generation of tolerogenic DCs in colon are poorly understood. We hypothesized that Slc5a8-mediated transport of SCFAs into DCs and consequent inhibition of HDACs induces tolerogenic phenotype in these cells. In support of our hypothesis, we found that butyrate and propionate induce the immune-suppressive enzyme Indoleamine 2,3-dioxygenase (IDO) in DCs in an Slc5a8-dependent manner. Further, these DCs are able suppress conversion of naïve T cells into interferon-γ (IFNγ) producing Th1 cells. Together, our data identify the SCFA transporter Slc5a8 as a key determinant of SCFA-mediated protection against intestinal inflammation.